/PRNewswire/ In recent years, scientists have used gene modification technologies to reprogram immune cells into therapeutics that can attack cancers. But.
T cells used in immunotherapy treatments can get exhausted and shut down by fighting cancer cells and tumors. Using a CRISPR-based edit on these cells’ genomes, researchers at UCSF and Gladstone Institutes have rendered the therapeutic cells more resilient against tumors.
Giving Immunotherapy Cells Resilience to Pass Stress Test miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.